Fountoulakis Konstantinos N, Gonda Xenia, Rihmer Zoltan, Fokas Costas, Iacovides Apostolos
Third Department of Psychiatry, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Ann Gen Psychiatry. 2008 Nov 13;7:22. doi: 10.1186/1744-859X-7-22.
Important methodological questions still exist concerning the Dexamethasone Suppression Test (DST), including the possibility of a better way of interpreting it. The aim of the present study was to explore the feasibility of an alternative way of interpreting DST results.
A total of 50 patients with major depression aged 41.0 +/- 11.4 years old participated in the study. Past and present suicide attempts were recorded. Psychometric assessment included the Hamilton Depression Rating Scale (HDRS), the Hamilton Anxiety Scale (HAS), the Newcastle Depression Diagnostic Scale (NDDS), the Diagnostic Melancholia Scale (DMS) and the General Assessment of Functioning (GAF) scale. The 1 mg DST protocol was used. Analysis methods included the chi square test and analysis of covariance (ANCOVA) with Fisher least significant difference (LSD) as post hoc tests.
In all, 34 patients (68%) were suppressors, 16 (32%) were non-suppressors and 14 patients had cortisol values above 5 microg/dl at baseline. Baseline cortisol level did not influence the classical DST interpretation. A total of 18 patients (36%) showed an increase of their cortisol levels after dexamethasone administration and 32 patients (64%) showed a decrease. Reducers had less melancholic features, similar levels of depression, better sleep and less suicidal thoughts in comparison to increasers. No relationship of DST to suicidality was found.
The present study explored the pattern of cortisol response to dexamethasone suppression and suggested an alternative way of coding and interpreting the DST on the basis of whether the cortisol levels remain stable or increase vs decrease after the administration of cortisol. The results put forward a complex way of understanding the relationship of the DST results with clinical symptoms.
关于地塞米松抑制试验(DST)仍存在重要的方法学问题,包括是否有更好的解释方法。本研究的目的是探讨一种解释DST结果的替代方法的可行性。
共有50名年龄在41.0±11.4岁的重度抑郁症患者参与了本研究。记录既往和当前的自杀未遂情况。心理测量评估包括汉密尔顿抑郁量表(HDRS)、汉密尔顿焦虑量表(HAS)、纽卡斯尔抑郁诊断量表(NDDS)、抑郁诊断量表(DMS)和功能总体评估(GAF)量表。采用1毫克DST方案。分析方法包括卡方检验和协方差分析(ANCOVA),并采用Fisher最小显著差异(LSD)作为事后检验。
总共34名患者(68%)为抑制者,16名(32%)为非抑制者,14名患者在基线时皮质醇值高于5微克/分升。基线皮质醇水平不影响经典的DST解释。共有18名患者(36%)在给予地塞米松后皮质醇水平升高,32名患者(64%)皮质醇水平下降。与皮质醇水平升高者相比,皮质醇水平下降者抑郁特征较少,抑郁程度相似,睡眠更好,自杀念头更少。未发现DST与自杀行为之间的关系。
本研究探讨了皮质醇对地塞米松抑制反应的模式,并提出了一种基于皮质醇给药后皮质醇水平是保持稳定还是升高或降低来对DST进行编码和解释的替代方法。结果提出了一种理解DST结果与临床症状关系的复杂方法。